CDK4 and sarcoma: However, this molecular finding does not assist in distinguishing DDLPS from ALT/WDLPS, as both sarcomas exhibit amplification of MDM2 and most often CDK4. While morphological differentiation is crucial in this context, it is often challenging, particularly in the sclerosing and inflammatory subtypes.